Monterey Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Monterey Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,527	Closed	-$232K	–	114
2023 Q4	$232K	Sell	4,527 -111	-2%	-$5.83K	0.1%	93
2023 Q3	$269K	Buy	4,638 +42	+0.9%	+$2.57K	0.14%	77
2023 Q2	$294K	Buy	4,596 +196	+4%	+$13.1K	0.14%	72
2023 Q1	$305K	Sell	4,400 -73	-2%	-$5.15K	0.16%	75
2022 Q4	$322K	Sell	4,473 -322	-7%	-$24.3K	0.17%	67
2022 Q3	$344K	Sell	4,795 -639	-12%	-$46.4K	0.21%	62
2022 Q2	$418K	Buy	5,434 +674	+14%	+$51.3K	0.24%	57
2022 Q1	$351K	Sell	4,760 -17	-0.4%	-$1.14K	0.17%	73
2021 Q4	$298K	Buy	4,777 +9	+0.2%	+$528	0.15%	85
2021 Q3	$282K	Buy	4,768 +8	+0.2%	+$527	0.16%	80
2021 Q2	$318K	Buy	4,760 +475	+11%	+$31K	0.18%	72
2021 Q1	$282K	Buy	4,285 +23	+0.5%	+$1.43K	0.16%	77
2020 Q4	$264K	Buy	4,262 +7	+0.2%	+$430	0.15%	73
2020 Q3	$257K	Buy	4,255 +8	+0.2%	+$481	0.17%	70
2020 Q2	$250K	Buy	4,247 +8	+0.2%	+$479	0.18%	63
2020 Q1	$236K	Sell	4,239 -343	-7%	-$21K	0.2%	55
2019 Q4	$294K	Buy	+4,582	New	+$262K	0.24%	56

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Monterey Private Wealth's BMY Position: Q1 2024 in Review

Monterey Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,527 shares — an estimated $232K sold.

Monterey Private Wealth first reported a position in BMY in Q4 2019 and held it in 17 quarters. The position peaked at $418K in Q2 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Monterey Private Wealth reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Monterey Private Wealth sold 4,527 Bristol-Myers Squibb shares in Q1 2024, an estimated $232K.
Monterey Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 17 quarters.
Monterey Private Wealth's Bristol-Myers Squibb position peaked at $418K in Q2 2022.
2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Monterey Private Wealth's 13F filing for Q1 2024, filed 9 Apr 2024.